NGS Relative Valuation - NGS Group AB

Watchlist Manager

Watchlist

Price: 2.34 SEK 0.43% Market Closed

Market Cap: kr58.1m

Relative Value

The Relative Value of one NGS stock under the Base Case scenario is 7.43 SEK. Compared to the current market price of 2.34 SEK, NGS Group AB is Undervalued by 69%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

NGS Relative Value

Base Case

Undervaluation 69%

Relative Value

Price

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
SE		NGS Group AB STO:NGS	58.1m SEK	0.2	-14.2	12.6	-196.7
US		CVS Health Corp NYSE:CVS	92.8B USD	0.2	52.5	13.6	13.6
US	C	Cigna Group XMUN:CGN	67.4B EUR	0.3	13.1	7.7	9.8
US		Cigna Corp NYSE:CI	69.7B USD	0.3	11.7	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	25.8B EUR	1.1	20.4	9.6	14.3
DE		Fresenius Medical Care AG XMUN:FME	23.5B EUR	1.2	24	9.2	17
US		Laboratory Corporation of America Holdings NYSE:LH	21.9B USD	1.6	24.9	12	17.4
US		Quest Diagnostics Inc NYSE:DGX	21.5B USD	1.9	21.7	11.8	15.9
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.9B EUR	0.6	11.2	5.4	9.9
US		Guardant Health Inc NASDAQ:GH	11.4B USD	11.6	-27.4	-30	-27.2
US		DaVita Inc NYSE:DVA	10.2B USD	0.7	13.7	7.1	9.7

				Revenue Growth	P/S to Growth
SE		NGS Group AB STO:NGS	Average P/S: 1.8 0.2	N/A	N/A
US		CVS Health Corp NYSE:CVS	0.2	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.3	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.2	3%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
US		Quest Diagnostics Inc NYSE:DGX	1.9	5%	0.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.6	3%	0.2
US		Guardant Health Inc NASDAQ:GH	11.6	30%	0.4
US		DaVita Inc NYSE:DVA	0.7	4%	0.2

				Earnings Growth	PEG
SE		NGS Group AB STO:NGS	Average P/E: 21.5 Negative Multiple: -14.2	N/A	N/A
US		CVS Health Corp NYSE:CVS	52.5	90%	0.6
US	C	Cigna Group XMUN:CGN	13.1	19%	0.7
US		Cigna Corp NYSE:CI	11.7	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	20.4	26%	0.8
DE		Fresenius Medical Care AG XMUN:FME	24	16%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	24.9	27%	0.9
US		Quest Diagnostics Inc NYSE:DGX	21.7	12%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.2	16%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -27.4	N/A	N/A
US		DaVita Inc NYSE:DVA	13.7	21%	0.7

				EBITDA Growth	EV/EBITDA to Growth
SE		NGS Group AB STO:NGS	Average EV/EBITDA: 9.9 12.6	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.6	28%	0.5
US	C	Cigna Group XMUN:CGN	7.7	4%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.6	10%	1
DE		Fresenius Medical Care AG XMUN:FME	9.2	7%	1.3
US		Laboratory Corporation of America Holdings NYSE:LH	12	10%	1.2
US		Quest Diagnostics Inc NYSE:DGX	11.8	6%	2
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.4	7%	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -30	N/A	N/A
US		DaVita Inc NYSE:DVA	7.1	4%	1.8

				EBIT Growth	EV/EBIT to Growth
SE		NGS Group AB STO:NGS	Average EV/EBIT: 13.4 Negative Multiple: -196.7	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.6	22%	0.6
US	C	Cigna Group XMUN:CGN	9.8	6%	1.6
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	14.3	13%	1.1
DE		Fresenius Medical Care AG XMUN:FME	17	17%	1
US		Laboratory Corporation of America Holdings NYSE:LH	17.4	18%	1
US		Quest Diagnostics Inc NYSE:DGX	15.9	9%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	9.9	17%	0.6
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -27.2	N/A	N/A
US		DaVita Inc NYSE:DVA	9.7	5%	1.9

NGS Group AB
STO:NGS

Relative Value

Valuation Multiples

Multiples Across Competitors

NGS Competitors Multiples
NGS Group AB Competitors

See Also

Company

Help

Tools

Stocks

NGS Group AB STO:NGS

Relative Value

Valuation Multiples

Multiples Across Competitors

NGS Competitors Multiples NGS Group AB Competitors

See Also

Company

Help

Tools

Stocks

NGS Group AB
STO:NGS

NGS Competitors Multiples
NGS Group AB Competitors